Fenoprofen activates both peroxisome proliferator activated receptors alpha and gamma (PPAR-α and -γ), to inhibit isozymes of cyclooxygenase COX-2, all of which are linked to obesity [60]. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.